Literature DB >> 33451778

Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule.

Hilary S Whitworth1, John Schiller2, Lauri E Markowitz3, Mark Jit4, Marc Brisson5, Evan Simpson6, Deborah Watson-Jones7.   

Abstract

Year:  2021        PMID： 33451778     DOI： 10.1016/j.vaccine.2020.12.031

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  2 in total

Review 1.  Prostate cancer and the human papilloma virus: causative association, role of vaccines, and the impact of the COVID-19 pandemic.

Authors:  Naomi Morka; Joseph M Norris; Mark Emberton; Daniel Kelly
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-06-18       Impact factor: 5.455

2.  Non-inferior antibody levels for HPV16/18 after extended two-dose schedules compared with a six-month interval: findings of a systematic review and meta-analysis.

Authors:  Aneisha Collins-Fairclough; Robine Donken; Bohdan Nosyk; Simon Dobson; Gina Ogilivie; Manish Sadarangani
Journal:  Hum Vaccin Immunother       Date:  2021-06-30       Impact factor: 4.526
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.